Loading...
Pilot Pharmacokinetic and Dosimetric Studies of (18)F-FPPRGD2: A PET Radiopharmaceutical Agent for Imaging α(v)β(3) Integrin Levels
PURPOSE: To assess the safety, biodistribution, and dosimetric properties of the positron emission tomography (PET) radiopharmaceutical agent fluorine 18 ((18)F) FPPRGD2 (2-fluoropropionyl labeled PEGylated dimeric RGD peptide [PEG3-E{c(RGDyk)}2]), which is based on the dimeric arginine-glycine–aspa...
Na minha lista:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Radiological Society of North America, Inc.
2011
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3121013/ https://ncbi.nlm.nih.gov/pubmed/21502381 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1148/radiol.11101139 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|